Middle East Coronary Artery Bypass Graft Cabg Market Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025–2030

The Middle East CABG market, valued at USD 520 million, is growing due to increasing coronary artery diseases, minimally invasive techniques, and healthcare investments in Saudi Arabia, UAE, and Qatar.

Region:Middle East

Author(s):Shubham

Product Code:KRAD3576

Pages:80

Published On:November 2025

About the Report

Base Year 2024

Middle East Coronary Artery Bypass Graft (CABG) Market Overview

  • The Middle East Coronary Artery Bypass Graft (CABG) Market is valued at USD 520 million, based on a five-year historical analysis. This growth is primarily driven by the increasing prevalence of coronary artery diseases, advancements in surgical techniques such as minimally invasive and off-pump procedures, and the rising number of elderly patients requiring cardiac interventions. The market is also supported by expanding healthcare infrastructure and significant investments in medical technology across the region, particularly in the Gulf Cooperation Council (GCC) countries .
  • Key players in this market include Saudi Arabia, the United Arab Emirates, and Qatar, which dominate due to their advanced healthcare systems, high healthcare expenditure, and a significant number of cardiac procedures performed annually. These countries have established a robust network of hospitals and cardiac specialty centers, further contributing to the overall growth of the CABG market .
  • In 2023, the Saudi Arabian government implemented the "Health Sector Transformation Program" under Vision 2030, issued by the Ministry of Health. This initiative includes a dedicated budget allocation for the development of specialized cardiac centers, aiming to enhance cardiac care services, improve access to CABG procedures, and elevate the quality of care for patients with coronary artery diseases .
Middle East Coronary Artery Bypass Graft (CABG) Market Size

Middle East Coronary Artery Bypass Graft (CABG) Market Segmentation

By Type:The CABG market can be segmented into various types, including On-pump CABG, Off-pump CABG, Minimally Invasive Direct CABG (MIDCAB), Hybrid Coronary Revascularization, and Others. Among these, Off-pump CABG is currently the most widely used technique in the Middle East, accounting for the largest market share. This method avoids the use of a heart-lung machine, reducing complications and recovery time for certain patient groups. The growing preference for off-pump procedures is driven by clinical outcomes and the expertise of surgical teams in the region .

Middle East Coronary Artery Bypass Graft (CABG) Market segmentation by Type.

By End-User:The CABG market is segmented by end-users, including Hospitals, Cardiac specialty centers, Ambulatory surgical centers, and Others. Hospitals remain the leading end-user segment, primarily due to their comprehensive facilities and resources to perform complex surgeries. They are equipped with advanced technology and skilled personnel, making them the preferred choice for patients requiring CABG. The increasing number of hospitals investing in cardiac care and the expansion of tertiary care centers further solidify their dominance in this segment .

Middle East Coronary Artery Bypass Graft (CABG) Market segmentation by End-User.

Middle East Coronary Artery Bypass Graft (CABG) Market Competitive Landscape

The Middle East Coronary Artery Bypass Graft (CABG) Market is characterized by a dynamic mix of regional and international players. Leading participants such as Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Edwards Lifesciences Corporation, Terumo Corporation, Johnson & Johnson (Ethicon/Cardiovascular & Specialty Solutions), Stryker Corporation, B. Braun Melsungen AG, Cook Medical LLC, Siemens Healthineers AG, Philips Healthcare (Royal Philips NV), GE HealthCare Technologies Inc., Canon Medical Systems Corporation, Getinge AB, LivaNova PLC contribute to innovation, geographic expansion, and service delivery in this space.

Medtronic plc

1949

Dublin, Ireland

Boston Scientific Corporation

1979

Marlborough, Massachusetts, USA

Abbott Laboratories

1888

Abbott Park, Illinois, USA

Edwards Lifesciences Corporation

2000

Irvine, California, USA

Terumo Corporation

1921

Tokyo, Japan

Company

Establishment Year

Headquarters

Regional Presence (number of Middle East countries served)

Revenue from CABG-related products/services (USD, latest year)

Market Share in Middle East CABG segment (%)

Number of CABG procedures supported (annual, Middle East)

Product Portfolio Breadth (number of CABG-related SKUs)

Regulatory Approvals/Certifications (e.g., SFDA, MOH, CE, FDA)

Middle East Coronary Artery Bypass Graft (CABG) Market Industry Analysis

Growth Drivers

  • Increasing Prevalence of Cardiovascular Diseases:The Middle East has witnessed a significant rise in cardiovascular diseases, with over 1.5 million deaths attributed to heart-related issues in the recent past. According to the World Health Organization, cardiovascular diseases account for approximately 45% of all deaths in the region. This alarming trend is driving the demand for CABG procedures, as healthcare systems strive to address the growing burden of heart diseases and improve patient outcomes through surgical interventions.
  • Advancements in Surgical Techniques and Technologies:The CABG market is benefiting from rapid advancements in surgical techniques, such as off-pump CABG and robotic-assisted surgeries. In the near future, the adoption of robotic-assisted surgeries is expected to increase by 30% in leading hospitals across the Middle East. These innovations enhance precision, reduce recovery times, and improve patient outcomes, thereby encouraging more patients to opt for CABG procedures as a viable treatment option for severe coronary artery disease.
  • Rising Geriatric Population:The geriatric population in the Middle East is projected to reach 50 million in the near future, according to the United Nations. This demographic shift is significant, as older adults are at a higher risk for cardiovascular diseases, necessitating surgical interventions like CABG. The increasing number of elderly patients is driving healthcare providers to expand their cardiac care services, thereby boosting the demand for CABG procedures across the region.

Market Challenges

  • High Cost of CABG Procedures:The average cost of a CABG procedure in the Middle East ranges from $15,000 to $30,000, which poses a significant barrier for many patients. With healthcare expenditure in the region averaging around $1,200 per capita in the near future, the financial burden of CABG can deter patients from seeking necessary surgical interventions. This challenge is particularly pronounced in lower-income populations, where affordability remains a critical issue.
  • Limited Access to Healthcare Facilities in Rural Areas:Approximately 30% of the Middle East's population resides in rural areas, where access to specialized healthcare facilities is severely limited. According to the World Bank, only 60% of rural residents have access to essential health services. This disparity in healthcare access creates significant challenges for patients requiring CABG, as they may face long travel distances and delays in receiving timely surgical care, ultimately impacting their health outcomes.

Middle East Coronary Artery Bypass Graft (CABG) Market Future Outlook

The future of the CABG market in the Middle East appears promising, driven by ongoing advancements in medical technology and an increasing focus on patient-centered care. As healthcare systems invest in expanding surgical facilities and integrating telemedicine, the accessibility and efficiency of CABG procedures are expected to improve. Additionally, the growing trend towards outpatient surgeries will likely reshape patient experiences, making CABG a more attractive option for those in need of cardiac interventions.

Market Opportunities

  • Expansion of Healthcare Infrastructure:The Middle East is witnessing significant investments in healthcare infrastructure, with over $50 billion allocated for new hospitals and clinics in the near future. This expansion will enhance access to CABG procedures, particularly in underserved areas, ultimately improving patient outcomes and increasing the number of surgeries performed annually.
  • Growth in Medical Tourism:The Middle East is emerging as a hub for medical tourism, attracting patients from around the globe seeking high-quality CABG procedures. In the near future, the region is expected to welcome over 1.2 million medical tourists, with cardiac surgeries being among the most sought-after services. This trend presents a lucrative opportunity for healthcare providers to expand their CABG offerings and cater to international patients.

Scope of the Report

SegmentSub-Segments
By Type

On-pump CABG

Off-pump CABG

Minimally Invasive Direct CABG (MIDCAB)

Hybrid Coronary Revascularization

Others

By End-User

Hospitals

Cardiac specialty centers

Ambulatory surgical centers

Others

By Region

GCC Countries (Saudi Arabia, UAE, Qatar, Kuwait, Oman, Bahrain)

Levant Region (Jordan, Lebanon, Iraq, Syria, Palestine)

North Africa (Egypt, Libya, Sudan, Morocco, Algeria, Tunisia)

Others

By Technology

Surgical instruments

Cardiopulmonary bypass systems

Imaging systems

Anesthesia equipment

Others

By Application

Elective surgeries

Emergency surgeries

Redo/repeat CABG

Others

By Investment Source

Private funding

Government funding

International aid

Others

By Policy Support

Government subsidies

Tax incentives

Grants for research and development

Others

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Ministry of Health, Saudi Food and Drug Authority)

Manufacturers and Producers of Medical Devices

Healthcare Providers and Hospitals

Medical Equipment Distributors

Health Insurance Companies

Pharmaceutical Companies

Industry Associations (e.g., Middle East Society of Cardiology)

Players Mentioned in the Report:

Medtronic plc

Boston Scientific Corporation

Abbott Laboratories

Edwards Lifesciences Corporation

Terumo Corporation

Johnson & Johnson (Ethicon/Cardiovascular & Specialty Solutions)

Stryker Corporation

B. Braun Melsungen AG

Cook Medical LLC

Siemens Healthineers AG

Philips Healthcare (Royal Philips NV)

GE HealthCare Technologies Inc.

Canon Medical Systems Corporation

Getinge AB

LivaNova PLC

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. Middle East Coronary Artery Bypass Graft (CABG) Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 Middle East Coronary Artery Bypass Graft (CABG) Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. Middle East Coronary Artery Bypass Graft (CABG) Market Analysis

3.1 Growth Drivers

3.1.1 Increasing prevalence of cardiovascular diseases
3.1.2 Advancements in surgical techniques and technologies
3.1.3 Rising geriatric population
3.1.4 Growing healthcare expenditure

3.2 Market Challenges

3.2.1 High cost of CABG procedures
3.2.2 Limited access to healthcare facilities in rural areas
3.2.3 Shortage of skilled healthcare professionals
3.2.4 Regulatory hurdles and compliance issues

3.3 Market Opportunities

3.3.1 Expansion of healthcare infrastructure
3.3.2 Increasing adoption of minimally invasive surgeries
3.3.3 Growth in medical tourism
3.3.4 Development of innovative CABG technologies

3.4 Market Trends

3.4.1 Shift towards outpatient CABG procedures
3.4.2 Integration of telemedicine in post-operative care
3.4.3 Rising demand for robotic-assisted surgeries
3.4.4 Focus on personalized medicine and patient-centric approaches

3.5 Government Regulation

3.5.1 Implementation of healthcare quality standards
3.5.2 Regulations on medical device approvals
3.5.3 Policies promoting healthcare accessibility
3.5.4 Guidelines for surgical practices and patient safety

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. Middle East Coronary Artery Bypass Graft (CABG) Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. Middle East Coronary Artery Bypass Graft (CABG) Market Segmentation

8.1 By Type

8.1.1 On-pump CABG
8.1.2 Off-pump CABG
8.1.3 Minimally Invasive Direct CABG (MIDCAB)
8.1.4 Hybrid Coronary Revascularization
8.1.5 Others

8.2 By End-User

8.2.1 Hospitals
8.2.2 Cardiac specialty centers
8.2.3 Ambulatory surgical centers
8.2.4 Others

8.3 By Region

8.3.1 GCC Countries (Saudi Arabia, UAE, Qatar, Kuwait, Oman, Bahrain)
8.3.2 Levant Region (Jordan, Lebanon, Iraq, Syria, Palestine)
8.3.3 North Africa (Egypt, Libya, Sudan, Morocco, Algeria, Tunisia)
8.3.4 Others

8.4 By Technology

8.4.1 Surgical instruments
8.4.2 Cardiopulmonary bypass systems
8.4.3 Imaging systems
8.4.4 Anesthesia equipment
8.4.5 Others

8.5 By Application

8.5.1 Elective surgeries
8.5.2 Emergency surgeries
8.5.3 Redo/repeat CABG
8.5.4 Others

8.6 By Investment Source

8.6.1 Private funding
8.6.2 Government funding
8.6.3 International aid
8.6.4 Others

8.7 By Policy Support

8.7.1 Government subsidies
8.7.2 Tax incentives
8.7.3 Grants for research and development
8.7.4 Others

9. Middle East Coronary Artery Bypass Graft (CABG) Market Competitive Analysis

9.1 Market Share of Key Players

9.2 Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Regional Presence (number of Middle East countries served)
9.2.3 Revenue from CABG-related products/services (USD, latest year)
9.2.4 Market Share in Middle East CABG segment (%)
9.2.5 Number of CABG procedures supported (annual, Middle East)
9.2.6 Product Portfolio Breadth (number of CABG-related SKUs)
9.2.7 Regulatory Approvals/Certifications (e.g., SFDA, MOH, CE, FDA)
9.2.8 R&D Investment as % of revenue
9.2.9 Distribution Network Strength (number of local partners/distributors)
9.2.10 Customer Satisfaction Score (Middle East, latest survey)

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 Medtronic plc
9.5.2 Boston Scientific Corporation
9.5.3 Abbott Laboratories
9.5.4 Edwards Lifesciences Corporation
9.5.5 Terumo Corporation
9.5.6 Johnson & Johnson (Ethicon/Cardiovascular & Specialty Solutions)
9.5.7 Stryker Corporation
9.5.8 B. Braun Melsungen AG
9.5.9 Cook Medical LLC
9.5.10 Siemens Healthineers AG
9.5.11 Philips Healthcare (Royal Philips NV)
9.5.12 GE HealthCare Technologies Inc.
9.5.13 Canon Medical Systems Corporation
9.5.14 Getinge AB
9.5.15 LivaNova PLC

10. Middle East Coronary Artery Bypass Graft (CABG) Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Budget allocation for healthcare
10.1.2 Decision-making processes
10.1.3 Evaluation criteria for procurement
10.1.4 Contracting practices

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Investment in healthcare facilities
10.2.2 Spending on medical equipment
10.2.3 Funding for research and development
10.2.4 Others

10.3 Pain Point Analysis by End-User Category

10.3.1 Challenges faced by hospitals
10.3.2 Issues in specialty clinics
10.3.3 Concerns of ambulatory surgical centers
10.3.4 Others

10.4 User Readiness for Adoption

10.4.1 Training and education needs
10.4.2 Infrastructure readiness
10.4.3 Financial readiness
10.4.4 Others

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Measurement of surgical outcomes
10.5.2 Cost savings analysis
10.5.3 Patient satisfaction metrics
10.5.4 Others

11. Middle East Coronary Artery Bypass Graft (CABG) Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market gaps identification

1.2 Value proposition development

1.3 Revenue model exploration

1.4 Customer segmentation analysis

1.5 Competitive landscape assessment


2. Marketing and Positioning Recommendations

2.1 Branding strategies

2.2 Product USPs

2.3 Target audience identification

2.4 Communication strategies

2.5 Digital marketing initiatives


3. Distribution Plan

3.1 Urban retail strategies

3.2 Rural NGO tie-ups

3.3 Online distribution channels

3.4 Partnerships with healthcare providers

3.5 Logistics and supply chain management


4. Channel & Pricing Gaps

4.1 Underserved routes

4.2 Pricing bands analysis

4.3 Competitor pricing strategies

4.4 Customer willingness to pay

4.5 Value-based pricing models


5. Unmet Demand & Latent Needs

5.1 Category gaps identification

5.2 Consumer segments analysis

5.3 Emerging trends and needs

5.4 Product development opportunities

5.5 Market entry barriers


6. Customer Relationship

6.1 Loyalty programs

6.2 After-sales service

6.3 Customer feedback mechanisms

6.4 Engagement strategies

6.5 Relationship management tools


7. Value Proposition

7.1 Sustainability initiatives

7.2 Integrated supply chains

7.3 Cost-effectiveness

7.4 Quality assurance

7.5 Innovation in service delivery


8. Key Activities

8.1 Regulatory compliance

8.2 Branding efforts

8.3 Distribution setup

8.4 Training and development

8.5 Performance monitoring


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product mix considerations
9.1.2 Pricing band strategies
9.1.3 Packaging options

9.2 Export Entry Strategy

9.2.1 Target countries analysis
9.2.2 Compliance roadmap development

10. Entry Mode Assessment

10.1 Joint Ventures

10.2 Greenfield investments

10.3 Mergers & Acquisitions

10.4 Distributor Model

10.5 Risk assessment


11. Capital and Timeline Estimation

11.1 Capital requirements

11.2 Timelines for market entry

11.3 Financial projections

11.4 Resource allocation

11.5 Milestone tracking


12. Control vs Risk Trade-Off

12.1 Ownership considerations

12.2 Partnerships evaluation

12.3 Risk management strategies

12.4 Control mechanisms

12.5 Exit strategies


13. Profitability Outlook

13.1 Breakeven analysis

13.2 Long-term sustainability

13.3 Profit margin assessment

13.4 Revenue forecasting

13.5 Cost management strategies


14. Potential Partner List

14.1 Distributors

14.2 Joint Ventures

14.3 Acquisition targets

14.4 Strategic alliances

14.5 Collaboration opportunities


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Activity planning
15.2.2 Milestone tracking
15.2.3 Performance evaluation
15.2.4 Resource allocation

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of published reports from health organizations and government health ministries in the Middle East
  • Review of academic journals and articles focusing on cardiovascular health and CABG procedures
  • Examination of market reports from industry associations related to cardiac surgery and medical devices

Primary Research

  • Interviews with cardiologists and cardiac surgeons specializing in CABG procedures
  • Surveys conducted with hospital administrators regarding CABG service offerings and patient demographics
  • Focus groups with patients who have undergone CABG to understand their experiences and outcomes

Validation & Triangulation

  • Cross-validation of findings through multiple expert interviews and secondary data sources
  • Triangulation of data from clinical studies, hospital records, and patient feedback
  • Sanity checks performed by a panel of healthcare experts to ensure data accuracy and relevance

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of the total CABG market size based on national healthcare expenditure data
  • Segmentation of the market by country, type of procedure, and patient demographics
  • Incorporation of trends in cardiovascular disease prevalence and surgical intervention rates

Bottom-up Modeling

  • Collection of data on the number of CABG surgeries performed annually across major hospitals
  • Estimation of average costs associated with CABG procedures, including surgery, hospitalization, and follow-up care
  • Analysis of market share held by various medical device manufacturers involved in CABG procedures

Forecasting & Scenario Analysis

  • Development of predictive models based on historical growth rates and emerging healthcare trends
  • Scenario analysis considering factors such as technological advancements and changes in healthcare policies
  • Projections for market growth through 2030 under different economic and demographic scenarios

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Cardiac Surgeons in Major Hospitals60Cardiac Surgeons
Hospital Administrators50Hospital Administrators, Operations Managers
Patients Post-CABG40Patients, Caregivers
Medical Device Suppliers40Sales Representatives, Product Managers
Health Insurance Providers40Policy Analysts, Claims Managers

Frequently Asked Questions

What is the current value of the Middle East Coronary Artery Bypass Graft (CABG) Market?

The Middle East CABG Market is valued at approximately USD 520 million, reflecting a five-year historical analysis. This growth is driven by the rising prevalence of coronary artery diseases and advancements in surgical techniques.

What factors are driving the growth of the CABG market in the Middle East?

Which countries dominate the Middle East CABG market?

What are the main types of CABG procedures available in the Middle East?

Other Regional/Country Reports

Indonesia Coronary Artery Bypass Graft Cabg Market

Malaysia Coronary Artery Bypass Graft Cabg Market

KSA Coronary Artery Bypass Graft Cabg Market

APAC Coronary Artery Bypass Graft Cabg Market

SEA Coronary Artery Bypass Graft Cabg Market

Vietnam Coronary Artery Bypass Graft Cabg Market

Other Adjacent Reports

KSA Cardiovascular Devices Market

Philippines Interventional Cardiology Market

Singapore Cardiac Surgery Instruments Market

Brazil Vascular Grafts Market

South Africa Heart Valve Replacement Market

Singapore Cardiac Monitoring Systems Market

Bahrain Minimally Invasive Surgery Market

Qatar Medical Imaging Equipment Market

Singapore Telemedicine Services Market

Vietnam Medical Tourism Market

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022